Skip to main content
main-content

Zeitschrift

Hepatology International

Hepatology International 1/2021

Ausgabe 1/2021

Inhaltsverzeichnis ( 23 Artikel )

16.01.2021 | Editorial | Ausgabe 1/2021

Sequential combination therapies for HBeAg-positive chronic hepatitis B: the search continues

Ankur Jindal, Manoj Kumar

21.01.2021 | Editorial | Ausgabe 1/2021

Is it time to spit? More evidence for the oral–gut–liver axis in liver disease

Chathur Acharya, Jasmohan S. Bajaj

30.12.2020 | Review Article | Ausgabe 1/2021 Open Access

Management of primary sclerosing cholangitis and its complications: an algorithmic approach

Michal Prokopič, Ulrich Beuers

06.02.2021 | Review Article | Ausgabe 1/2021 Open Access

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

Yana Geng, Klaas Nico Faber, Vincent E. de Meijer, Hans Blokzijl, Han Moshage

05.02.2021 | Review Article | Ausgabe 1/2021 Open Access

Regression of portal hypertension: underlying mechanisms and therapeutic strategies

Sonia Selicean, Cong Wang, Sergi Guixé-Muntet, Horia Stefanescu, Norifumi Kawada, Jordi Gracia-Sancho

29.09.2020 | Original Article | Ausgabe 1/2021

Efficacy of peg-interferon–nucleoside analog sequential optimization therapy in HBeAg-positive patients with CHB

Wei Xu, Qiang Li, Chenlu Huang, Qiankun Hu, Xun Qi, Yuxian Huang, Jiming Zhang, Liang Chen

03.02.2021 | Original Article | Ausgabe 1/2021 Open Access

Liver damage favors the eliminations of HBV integration and clonal hepatocytes in chronic hepatitis B

Gang Hu, Ming X. Huang, Wei Y. Li, Chong J. Gan, Wen X. Dong, Xiao M. Peng

04.01.2021 | Original Article | Ausgabe 1/2021

Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients

Matt Liu, Tai-Chung Tseng, Dae Won Jun, Ming-Lun Yeh, Huy Trinh, Grace L. H. Wong, Chien-Hung Chen, Cheng-Yuan Peng, Sung Eun Kim, Hyunwoo Oh, Min-Sun Kwak, Michael Cheung, Hidenori Toyoda, Yao-Chun Hsu, Jae Yoon Jeong, Eileen L. Yoon, Teerapat Ungtrakul, Jian Zhang, Qing Xie, Sang Bong Ahn, Masaru Enomoto, Jae-Jun Shim, Chris Cunningham, Soung Won Jeong, Yong Kyun Cho, Eiichi Ogawa, Rui Huang, Dong-Hyun Lee, Hirokazu Takahashi, Pei-Chien Tsai, Chung-Feng Huang, Chia-Yen Dai, Cheng-Hao Tseng, Satoshi Yasuda, Ritsuzo Kozuka, Jiayi Li, Christopher Wong, Clifford C. Wong, Changqing Zhao, Joseph Hoang, Yuichiro Eguchi, Chao Wu, Yasuhito Tanaka, Ed Gane, Tawesak Tanwandee, Ramsey Cheung, Man-Fung Yuen, Hyo-Suk Lee, Ming-Lung Yu, Jia-Horng Kao, Hwai-I. Yang, Mindie H. Nguyen

18.01.2021 | Original Article | Ausgabe 1/2021

Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy

Xiaoning Wu, Jialing Zhou, Yameng Sun, Huiguo Ding, Guofeng Chen, Wen Xie, Hongxin Piao, Xiaoyuan Xu, Wei Jiang, Hui Ma, Anlin Ma, Yongpeng Chen, Mingyi Xu, Jilin Cheng, Youqing Xu, Tongtong Meng, Bingqiong Wang, Shuyan Chen, Yiwen Shi, Yuanyuan Kong, Xiaojuan Ou, Hong You, Jidong Jia

09.01.2021 | Original Article | Ausgabe 1/2021

Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis

Jean-Frédéric Blanc, Faiza Khemissa, Jean-Pierre Bronowicki, Carole Monterymard, Jean-Marc Perarnau, Vincent Bourgeois, Stéphane Obled, Meher Ben Abdelghani, Isabelle Mabile-Archambeaud, Roger Faroux, Jean-François Seitz, Christophe Locher, Hélène Senellart, Anne-Laure Villing, Franck Audemar, Charlotte Costentin, Gaël Deplanque, Sylvain Manfredi, Julien Edeline, for the PRODIGE 21 collaborators

05.02.2021 | Original Article | Ausgabe 1/2021

One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment

Tai-Chung Tseng, Jonggi Choi, Mindie H. Nguyen, Cheng-Yuan Peng, Spyros Siakavellas, George Papatheodoridis, Chia-Chi Wang, Young-Suk Lim, Hsueh-Chou Lai, Huy N. Trinh, Christopher Wong, Clifford Wong, Jian Zhang, Jiayi Li, Jia-Horng Kao

25.01.2021 | Original Article | Ausgabe 1/2021

S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma

Lu-Nan Qi, Liang Ma, Fei-Xiang Wu, Yuan-Yuan Chen, Wan-Ting Xing, Zhi-Jun Jiang, Jian-Hong Zhong, Zu-Shun Chen, Wen-Feng Gong, Jia-Zhou Ye, Hong-Hao Li, Jin-Jie Shang, Bang-De Xiang, Le-Qun Li

29.01.2021 | Original Article | Ausgabe 1/2021 Open Access

Prevalence of nonalcoholic fatty liver disease in mental disorder inpatients in China: an observational study

Qiuyue Ma, Fude Yang, Botao Ma, Wenzhan Jing, Jue Liu, Moning Guo, Juan Li, Zhiren Wang, Min Liu

26.01.2021 | Original Article | Ausgabe 1/2021

Sorafenib for advanced hepatocellular carcinoma provides better prognosis after liver transplantation than without liver transplantation

Soon Kyu Lee, Jeong Won Jang, Heechul Nam, Pil Soo Sung, Hee Yeon Kim, Jung Hyun Kwon, Sung Won Lee, Do Seon Song, Chang Wook Kim, Myeong Jun Song, Ho Joong Choi, Young Kyoung You, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

02.01.2021 | Original Article | Ausgabe 1/2021

Acute liver failure in Budd–Chiari syndrome and a model to predict mortality

Paul J. Thuluvath, Joseph J. Alukal, Talan Zhang

01.01.2021 | Original Article | Ausgabe 1/2021

Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis

Xin Zeng, Xia Sheng, Pei-Qin Wang, Hai-Guang Xin, Yi-Bin Guo, Yong Lin, Jia-Wei Zhong, Cheng-Zhi He, Jie Yin, Tao-Tao Liu, Wei-Juan Ma, Xiao Xiao, Pei-Mei Shi, Zong-Li Yuan, Ling Yang, Xiong Ma, Jian-Ming Xu, Xi-Zhong Shen, Chang-Qing Yang, Xuan Zhu, Nong-Hua Lv, Wei-Fen Xie

24.01.2021 | Original Article | Ausgabe 1/2021

GATA6 modulates the ductular reaction to bile duct ligation

Marjut Pihlajoki, Tea Soini, Rebecca B. Cochran, Emmi Liljeström, Jiansheng Huang, David A. Rudnick, Dennis J. Dietzen, Antti Kyrönlahti, Mikko P. Pakarinen, Markku Heikinheimo, David B. Wilson

10.01.2021 | Original Article | Ausgabe 1/2021

Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan

Fu-Shun Yen, James Cheng-Chung Wei, Hei-Tung Yip, Chii-Min Hwu, Ming-Chih Hou, Chih-Cheng Hsu

19.09.2020 | Original Article | Ausgabe 1/2021

Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis

Y. Lapidot, A. Amir, S. Ben-Simon, E. Veitsman, O. Cohen-Ezra, Y. Davidov, P. Weiss, T. Bradichevski, S. Segev, O. Koren, Z. Ben-Ari, M. Safran

06.02.2021 | COVID-19 | Original Article | Ausgabe 1/2021 Zur Zeit gratis

Implications of liver injury in risk-stratification and management of patients with COVID-19

Jiaofang Shao, Yuan Liang, Yan Li, Rong Ding, Mengyan Zhu, Wenhua You, Ziyu Wang, Bin Huang, Min Wu, Tingting Zhang, Kening Li, Wei Wu, Lingxiang Wu, Qianghu Wang, Xinyi Xia, Shukui Wang, Ling Lu

09.01.2021 | COVID-19 | Letter to the Editor | Ausgabe 1/2021 Zur Zeit gratis

Reductions in liver cirrhosis hospitalizations during the COVID-19 pandemic

Jianglei Li, Deliang Liu, Jin Yan, Yuyong Tan

27.01.2021 | COVID-19 | Letter to the Editor | Ausgabe 1/2021 Zur Zeit gratis

How can we reduce the impact of COVID-19 pandemic on timely access to liver transplantation in children?

Mettu Srinivas Reddy, Jagadeesh Menon, Abdul Rahman Hakeem, Shivakumar Murugesan, Gomathy Narasimhan, Naresh Shanmugham, Mohamed Rela

28.01.2021 | COVID-19 | Letter to the Editor | Ausgabe 1/2021 Zur Zeit gratis

Chronic liver disease independently associated with COVID-19 severity: evidence based on adjusted effect estimates

Haiyan Yang, Jie Xu, Xuan Liang, Li Shi, Yadong Wang

Aktuelle Ausgaben

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise